The role of APOE in cerebrovascular dysfunction - Wikidata - wikimedia - TriplyDB

The role of APOE in cerebrovascular dysfunction

The role of APOE in cerebrovascular dysfunction

http://www.wikidata.org/entity/Q36813704

about

Apolipoprotein E ε4: A Possible Risk Factor of Intracranial Pressure and White Matter Perfusion in Good-Grade Aneurysmal Subarachnoid Hemorrhage Patients at Early Stage.Epidermal growth factor prevents APOE4-induced cognitive and cerebrovascular deficits in female mice.Higher Brain Perfusion May Not Support Memory Functions in Cognitively Normal Carriers of the ApoE ε4 Allele Compared to Non-Carriers.Epidermal growth factor prevents APOE4 and amyloid-beta-induced cognitive and cerebrovascular deficits in female mice.Apolipoprotein E metabolism and functions in brain and its role in Alzheimer's disease Gene-environment interaction between lead and Apolipoprotein E4 causes cognitive behavior deficits in mice.Neuroimaging Feature Terminology: A Controlled Terminology for the Annotation of Brain Imaging Features.The Relationship Between Apolipoprotein ε4 Carrier Status and Sleep Characteristics in Cognitively Normal Older Adults.EFAD transgenic mice as a human APOE relevant preclinical model of Alzheimer's disease.Peripheral Inflammation, Apolipoprotein E4, and Amyloid-β Interact to Induce Cognitive and Cerebrovascular Dysfunction.In Vitro Assays to Assess Blood-brain Barrier Mesh-like Vessel Formation and Disruption.The effects of apolipoprotein E genotype, α-synuclein deficiency, and sex on brain synaptic and Alzheimer's disease-related pathology.Apolipoprotein E as a novel therapeutic neuroprotection target after traumatic spinal cord injury.Insulin resistance is associated with lower arterial blood flow and reduced cortical perfusion in cognitively asymptomatic middle-aged adults.Apolipoprotein E4 mediates insulin resistance-associated cerebrovascular dysfunction and the post-prandial response.Neurocognitive Function after Cardiac Surgery: From Phenotypes to Mechanisms.Cerebrovascular pathology: the dark side of neurodegeneration.Anserine/Carnosine Supplementation Preserves Blood Flow in the Prefrontal Brain of Elderly People Carrying APOE e4.APOE and Alzheimer’s Disease: Neuroimaging of Metabolic and Cerebrovascular Dysfunction.Visual Features in Alzheimer's Disease: From Basic Mechanisms to Clinical Overview Meta-Analysis of the Relationship between the Gene and the Onset of Parkinson's Disease Dementia Apoε4 disrupts neurovascular regulation and undermines white matter integrity and cognitive function

P2860

Q33575923-51155745-D956-4C4C-8A3D-8243E6F16AB4 Q33774995-9FA3D3D1-F5A6-4056-92B2-ADF1EAA03C3F Q37034226-FDDFF51E-A997-4461-ABB1-31E4B91FA3DF Q37374629-F89655DC-D05E-4A2A-BEAB-FCAA792CE3A5 Q37557940-0F36106E-1E00-4996-AFBD-0A28E0D3A57C Q37630982-3133CABA-E047-46C0-AF4F-331B8264EBA2 Q38430889-7DF0A4C0-3AE1-4B94-AC3F-55857A5A3BEF Q38659728-B51C60BF-0B2A-4CCA-AA44-93E29C5E1EA6 Q38733357-169A6D4C-69AD-4DA1-9B42-6AC9154C146D Q41087339-4F181676-270F-4981-87C5-AEF9B4BCD15D Q42511580-6036A710-0EB2-4B78-8AA4-DB5A535DC117 Q47107297-28270A87-4686-4B19-8039-F6884BC89054 Q47619892-43BAC6D1-11EF-462F-BAD6-7E463FC312B9 Q48046400-3E38D2C4-88AE-47BB-A290-FA00CDDE2539 Q50035045-07AABD2E-3C8F-41AE-AFD6-8F48D084DF3D Q52604751-C61E7875-A72C-4C05-8A80-05CF44F90288 Q53125875-14EEAD81-06E2-41CF-9139-CE16BB125429 Q55345172-B5AD3A6F-F180-4978-9C5A-861C55FC3725 Q55373234-A8F3DCD1-FFA8-44BA-8431-02AD5DCE4DA0 Q58567916-333512A7-DD77-46FB-895E-0DACF4CAAC59 Q58567981-77B71888-710F-4624-8E26-A0BEAAB5DFF9 Q58719840-CB5D9B69-EE0D-4BFF-8FCC-1582035639CA

P2860

The role of APOE in cerebrovascular dysfunction

http://www.wikidata.org/entity/Q36813704

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

The role of APOE in cerebrovascular dysfunction

@ast

The role of APOE in cerebrovascular dysfunction

@en

type

label

The role of APOE in cerebrovascular dysfunction

@ast

The role of APOE in cerebrovascular dysfunction

@en

prefLabel

The role of APOE in cerebrovascular dysfunction

@ast

The role of APOE in cerebrovascular dysfunction

@en

P1433

Q36813704-04E45C11-74D9-4D39-B169-7AD7CAEDD9EC

P1476

Q36813704-029692A1-BFA8-40D0-BEA5-D68130622421

P2093

Q36813704-15D8498C-5981-4668-81B1-90B3A346CF65

Q36813704-5B244C36-A24E-4887-A135-B5E36924285E

Q36813704-6210C1F0-9BFA-4E5F-9CD9-965A9BFE022F

Q36813704-D8375D87-FE72-4CD3-B36A-5695F36FB650

Q36813704-EFC4DB36-1FC0-455C-90B7-0D9EE96010C3

Q36813704-F9A9E762-1E59-4EF2-AC4F-FA457A079E52

P2860

Q36813704-00D507F0-FA07-4B23-B909-41B4D0250314

Q36813704-03B8A83E-0376-4D01-8319-4D6D4A3867F8

Q36813704-05B27982-CD21-4324-A144-FD0F3240DDBF

Q36813704-08E9252E-B487-43DC-B41A-7378047982D7

Q36813704-0B1196A0-EDAD-4642-91C8-56E86F4990FE

Q36813704-0C612FC1-113F-42D1-A623-070615CB9F3C

Q36813704-0D8817B1-1AE0-4ABB-BD20-9C470B6D9A31

Q36813704-0F66CBA2-14E1-4A9E-869F-1C0FF0C2A6D4

Q36813704-1259AC30-29B3-4606-BAC0-99BB5878609D

Q36813704-147FA93C-531D-44CD-94E0-FA3FC9DAA1AB

P2888

Q36813704-6BCA059E-5458-4E52-B9E7-EBB3EAE85CC4

P304

Q36813704-68016793-2FCB-4F13-B210-C4FFCD73C473

P31

Q36813704-2E6EB2C6-547E-44FC-898A-5AA1E4928EC1

P356

Q36813704-EB708C5E-528B-4D61-AAA0-B9D79D606214

P433

Q36813704-0A03D61F-63F8-49E2-BEF8-F2FB6A2BBB44

P478

Q36813704-8D42BEC8-307B-4F82-811C-75B84C15797F

P50

Q36813704-7E98C4DD-2954-4B3A-A598-3BA3F058C678

P577

Q36813704-AC6DCB82-9419-42CE-B9AF-7B18B9262A44

P5875

Q36813704-3AC0A3CB-443F-4D7C-A17E-B1B18309F9F1

P698

Q36813704-49D69DC6-7A08-42AC-90AE-6B4233F1FEB0

P932

Q36813704-C1852318-CA95-46EF-947F-1BB9CEE97FA6

P356

S00401-016-1547-Z

P1433

Acta Neuropathologica

P1476

The role of APOE in cerebrovascular dysfunction

@en

P2093

Felecia M Marottoli

http://www.w3.org/2001/XMLSchema#string

Guojun Bu

http://www.w3.org/2001/XMLSchema#string

Kevin P Koster

http://www.w3.org/2001/XMLSchema#string

Leon M Tai

http://www.w3.org/2001/XMLSchema#string

Riya Thomas

http://www.w3.org/2001/XMLSchema#string

Takahisa Kanekiyo

http://www.w3.org/2001/XMLSchema#string

P2860

Reduction in DHA transport to the brain of mice expressing human APOE4 compared to APOE2

Disruption of arterial perivascular drainage of amyloid-β from the brains of mice expressing the human APOE ε4 allele

APOE-modulated Aβ-induced neuroinflammation in Alzheimer's disease: current landscape, novel data, and future perspective

Abnormal lipoprotein receptor-binding activity of the human E apoprotein due to cysteine-arginine interchange at a single site

Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy

Association between white matter hyperintensity severity and cognitive impairment according to the presence of the apolipoprotein E (APOE) ε4 allele in the elderly: retrospective analysis of data from the CREDOS study.

APOE genotype and MRI markers of cerebrovascular disease: systematic review and meta-analysis.

The effects of APOE-ε4 on the BOLD response.

APOE associations with severe CAA-associated vasculopathic changes: collaborative meta-analysis.

Relationship between cyclophilin a levels and matrix metalloproteinase 9 activity in cerebrospinal fluid of cognitively normal apolipoprotein e4 carriers and blood-brain barrier breakdown

P2888

s00401-016-1547-z

P304

709-723

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00401-016-1547-Z

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

131

http://www.w3.org/2001/XMLSchema#string

P50

P577

2016-02-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

294919637

http://www.w3.org/2001/XMLSchema#string

P698

26884068

http://www.w3.org/2001/XMLSchema#string

P932

4837016

http://www.w3.org/2001/XMLSchema#string